MEP of the week

Lobby organisation

Novartis International AG

Business / industry · Health & pharma · HQ: Switzerland · Transparency Register entry

As of 9 September 2026, Novartis International AG appears in 103 declared MEP meetings (69 different MEPs), most often with European People's Party.

103
declared meetings
with current MEPs
69
MEPs met
€2.5M/yr
declared lobbying spend
self-reported to the register
3.2
lobbyists
full time equivalent

In their own words

“Bringing breakthroughs to more patients At Novartis, we don’t just discover life-changing medicines, we're part of a broader effort to help ensure medicines reach the people who need them most, wherever they live, because the true value of innovation lies in its ability to improve lives. Ensuring people everywhere can benefit from the latest medical breakthroughs is a shared global…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 103 declared meetings, by the meeting MEP's political group.

European People's Party5351%
Socialists & Democrats1717%
Renew Europe1515%
European Conservatives & Reformists88%
Patriots for Europe77%
Greens/EFA22%
The Left11%

Meetings by year

Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (32 in 2026).

2020
5
2021
2
2022
2
2023
12
2024
27
2025
23
2026
32

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Lukas Mandl
5 meetings · EPP
Tomislav Sokol
5 meetings · EPP
Nicolás González Casares
4 meetings · S&D
Sirpa Pietikäinen
4 meetings · EPP
Tiemo Wölken
3 meetings · S&D

The 15 most recent declared meetings

DateMEPSubject
27 Aug 2026Lukas MandlBiotech Act
8 Jul 2026Lukas MandlBiotech Act I
3 Jul 2026Billy KelleherEU-US Relations / Clinical Trials / Bio Tech Act
11 Jun 2026João Cotrim de FigueiredoCompetitividade europeia, investigação e inovação, reforço do Mercado Único e a agenda de segurança económica
10 Jun 2026Aurelijus VerygaBiotechnology Innovation, Health Policy and European Competitiveness
10 Jun 2026Zala TomašičAnnual meeting with Slovenian pharmaceutical industry
10 Jun 2026Marta TemidoApresentação do contributo e as principais iniciativas da Novartis em Portugal
10 Jun 2026Margarita de la Pisa CarriónBIOTECH ACT
10 Jun 2026Elżbieta Katarzyna ŁukacijewskaBiotech Act
10 Jun 2026Sérgio HumbertoBiotech
10 Jun 2026Sérgio GonçalvesHealth
10 Jun 2026Paulo CunhaBiotech Act
9 Jun 2026Auke ZijlstraBiotech
9 Jun 2026Marie Toussaintbiotech
9 Jun 2026Kristoffer StormDiff. SANT topic

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.